Ignite Creation Date:
2024-05-06 @ 1:49 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04133337
Status:
UNKNOWN
Last Update Posted:
2019-10-21
First Post:
2019-10-17
Brief Title:
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Sichuan Cancer Hospital and Research Institute
Organization Data
Organization:
Sichuan Cancer Hospital and Research Institute
Class:
OTHER
Study ID:
HR-SHR-NSCLC201906
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Juan LI MD
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan Cancer Hospital and Research Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu HengRui Medicine Co Ltd | INDUSTRY |